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Abstract
Background: Rho1 is a small GTPase of the Ras superfamily that serves as the central component in a highly conserved
signaling pathway that regulates tissue morphogenesis during development in all animals. Since there is tremendous
diversity in the upstream signals that can activate Rho1 as well as the effector molecules that carry out its functions, it is
important to define relevant Rho1-interacting genes for each morphogenetic event regulated by this signaling pathway.
Previous work from our lab and others has shown that Rho signaling is necessary for the morphogenesis of leg imaginal
discs during metamorphosis in Drosophila, although a comprehensive identification of Rho1-interacting genes has not been
attempted for this process.
Methodology/Principal Findings: We characterized an amorphic allele of Rho1 that displays a poorly penetrant dominant
malformed leg phenotype and is capable of being strongly enhanced by Rho1-interacting heterozygous mutations. We then
used this allele in a second-site noncomplementation screen with the Exelixis collection of molecularly defined deficiencies
to identify Rho1-interacting genes necessary for leg morphogenesis. In a primary screen of 461 deficiencies collectively
uncovering ,50% of the Drosophila genome, we identified twelve intervals harboring Rho1-interacting genes. Through
secondary screening we identified six Rho1-interacting genes including three that were previously identified (RhoGEF2,
broad, and stubbloid), thereby validating the screen. In addition, we identified Cdc42, Rheb and Sc2 as novel Rho1-interacting
genes involved in adult leg development.
Conclusions/Significance: This screen identified well-known and novel Rho1-interacting genes necessary for leg
morphogenesis, thereby increasing our knowledge of this important signaling pathway. We additionally found that Rheb
may have a unique function in leg morphogenesis that is independent of its regulation of Tor.
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Introduction
Cell shape changes, cell rearrangements, oriented cell divisions
and regulated cell death collectively shape tissues and ultimately
influence the development of the organism as a whole. These
processes, generically referred to as morphogenesis, are the
underlying mechanisms for numerous developmental events
including gastrulation, neurulation, organogenesis and metamor-
phosis. Morphogenetic processes are largely driven by regulated
changes of the actin cytoskeleton. Members of the highly
conserved Rho family of small GTPases are key regulators of
the actin cytoskeleton (reviewed in [1,2]), and genetic and
pharmacological studies in a variety of organisms have demon-
strated critical roles for Rho, Rac and Cdc42 in regulating specific
morphogenetic events during development. For example, Rho
signaling has been implicated in neural tube closure [3] and
cardiac morphogenesis [4] during vertebrate embryogenesis,
whereas Rac signaling is critical for neurite outgrowth in
vertebrates, worms and flies [5-7], and Cdc42 signaling plays
similar roles in neurite outgrowth and axon guidance in
vertebrates [8,9].
Drosophila melanogaster has proven to be an excellent model
organism for elucidating the function of Rho proteins during
development and for identifying genes that function in concert
with Rho proteins to transduce signals through these GTPases
(reviewed in [10]). The Drosophila genome encodes one Rho gene
(Rho1), one Cdc42 gene (Cdc42), three Rac genes (Rac1, Rac2, and
Mtl), and several additional, more divergent, Rho family genes
(e.g. RhoBTB and RhoL). In Drosophila, loss of function genetic
analysis has demonstrated a role for Rho1 signaling during
oogenesis, and for cellularization of the blastoderm embryo,
gastrulation, dorsal closure, and head involution during embryo-
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7574
genesis [11–13]. Similarly, complete loss of all three Rac genes
leads to defects in dorsal closure and neural development [7],
whereas zygotic loss of Cdc42 results in defects in germ band
retraction during embryogenesis [14].
Like all members of the Rho family, Rho1 functions primarily
as a molecular switch, alternating between an inactive, GDP-
bound state and an active, GTP-bound form (reviewed in [1]).
Guanine nucleotide exchange factors (GEFs) activate Rho1 by
removing bound GDP, whereas GTPase activating proteins
(GAPs) stimulate the weak GTPase activity of Rho1, thereby
inactivating it. In certain contexts, guanine nucleotide dissociation
inhibitors (GDIs) bind to and sequester GDP-bound Rho1,
reinforcing the inactive Rho1 state. A number of effector proteins
can bind activated Rho1 to transduce signals in specific ways. For
example, Rho kinase is a serine/threonine kinase that regulates
contractile events at the actin cytoskeleton primarily by phos-
phorylating and thereby inactivating the myosin binding subunit
of the myosin phosphatase complex (reviewed in [15]). Since
myosin phosphatase normally dephosphorylates the myosin
regulatory light chain (MRLC; encoded by spaghetti squash or sqh
in Drosophila), the net effect of activated Rho1 signaling through
Rho kinase is an increase in the phosphorylation of MRLC.
Phospho-MRLC induces a conformational change in the myosin
heavy chain (encoded by zipper or zip in Drosophila) that increases
the ability of myosin to bind to actin filaments, thereby generating
a chemomechanical force on the actin cytoskeleton sufficient for
cell shape changes.
Less is known about the upstream events that activate Rho1
signaling during Drosophila development. RhoGEF proteins
directly activate Rho1, but the Drosophila genome encodes more
than 20 genes that are predicted to have RhoGEF activity, some of
which may have preferential specificity for a single Rho family
member, whereas others may be more promiscuous. In addition,
the mechanisms by which specific RhoGEFs are activated to signal
through Rho1 are complex and not fully understood.
The morphogenesis of leg imaginal discs that occurs during
Drosophila metamorphosis is a particularly useful genetic model for
studying Rho1 signaling. Adult legs are derived from imaginal
discs that were specified during embryogenesis and underwent
extensive proliferation and patterning during larval development
(reviewed in [16]). At the end of the third larval instar each of the
leg imaginal discs consists of a single-layered columnar epithelium
that is covered and apposed by a squamous peripodial epithelium.
In response to the late larval pulse of the steroid hormone
ecdysone that triggers puparium formation and initiates meta-
morphosis, these flat epithelial discs are transformed into
rudimentary adult legs in approximately 12 hours (reviewed in
[17]). Classical studies by the Fristrom lab and more recent
imaging studies have revealed that this morphogenetic process is
largely driven by changes in cell shape and by cell rearrangements
[18–20]. Furthermore, studies by Fristrom and Fristrom [21]
demonstrated that the elongation and eversion of the leg imaginal
discs could be reversibly inhibited by cytochalasin B, indicating a
central role for the actin cytoskeleton in driving leg disc
morphogenesis. Not surprisingly, independent genetic modifier
screens using zip and an ecdysone-induced transcription factor,
broad, have identified genes in the Rho signaling pathway as
playing a critical role in regulating leg morphogenesis [22–25].
Similar experiments also demonstrated robust genetic interactions
between the ecdysone-induced type II transmembrane serine
protease stubbloid (sbd) and components of the Rho signaling
pathway [26].
As a means to identify genes that function in concert with Rho1
during leg morphogenesis we have conducted a modifier screen
using an amorphic allele of Rho1 and the Exelixis collection of
molecularly defined deficiencies [27]. Screening through a
collection of 461 deficiencies that collectively uncover ,50% of
the Drosophila genome, we identified 12 deficiencies that likely
contain Rho1-interacting genes necessary for leg morphogenesis.
Included in this set were deficiencies that removed broad, RhoGEF2
and stubbloid, three genes that had previously been identified as
interacting with Rho1 during leg imaginal disc morphogenesis.
Further, we were able to identify Cdc42, Rheb, and Sc2 as likely
Rho1-interacting genes.
Materials and Methods
Drosophila stocks
All Drosophila stocks were maintained on media consisting of
corn meal, sugar, yeast, and agar in incubators maintained at a
constant temperature of 21uC, or in a room that typically
fluctuated between 21uC and 22.5uC. Many of the deficiency
stocks used in this study were generated by Exelixis, Inc., and
obtained from the Bloomington Drosophila stock center at Indiana
University (Bloomington, IN) [27]. Other deficiency stocks and
specific mutations used in the screen were also obtained from the
Bloomington Drosophila stock center. The Rho1E(br)233 and
Rho1E(br)246 stocks used in this study were isolated in a screen for
dominant modifiers of broad [25]. The zipE(br), Rho1J3.8, and
Rho1E3.10 stocks were obtained from S. Halsell (James Madison
University; [23,28]). The RhoGEF211-3 stock was obtained from L.
von Kalm (University of Central Florida; [26]). Dll-Gal4, UAS-
Rheb.Pa2, UAS-Rheb.Pa3, and UAS-PI3K92E.CAAX were obtained
from the Bloomington Drosophila stock center. Genetic experiments
were conducted in incubators controlled at a constant temperature
of either 21uC or 25uC, as indicated.
Characterization of Rho1E(br)233 and Rho1E(br)246
Rho1E(br)233 and Rho1E(br)246 were balanced with CyO, P{w+, Dfd-
EYFP} [29] to allow for unambiguous identification of homozy-
gous mutant embryos starting at ,12 hours after egg laying.
Genomic DNA isolated from homozygous mutant late embryos
was sequenced at the DNA Facility of the Iowa State University
Office of Biotechnology (Ames, IA). Lethal phase analyses were
performed by collecting homozygous mutant embryos produced
through a four hour egg lay of Rho1E(br)246/CyO, P{w+, ActGFP} or
Rho1E(br)233/CyO, P{w+, ActGFP} at 25uC, and determining the
percentage of unhatched embryos after 48 hours. Non-hatched
embryos were then dechorionated in 50% bleach, mounted on
microscope slides in Hoyer’s medium and subsequently examined
for cuticular phenotypes on a Nikon Eclipse 80i compound
microscope.
RNA isolation and northern blot analysis
Non YFP-expressing embryos were isolated from 4 hour
collections of Rho1E(br)246/CyO, P{w+, Dfd-EYFP}, Rho1E(br)233/
CyO, P{w+, Dfd-EYFP}, or w1118 that were aged to be 12–16 hours
after egg laying (AEL), 16–20 AEL, or 20–24 hours AEL. ,100
embryos from each collection were dechorionated and lysed in
Tripure isolation reagent (Roche Applied Science, Indianapolis,
IN). Total RNA was extracted from these lysates, and approxi-
mately 10 mg of total RNA per sample were separated by
formaldehyde agarose gel electrophoresis and transferred to a
nylon membrane (GeneScreen Plus, PerkinElmer, Waltham, MA).
The membrane was hybridized and stripped as described by [30].
Specific probes were labeled by random priming of gel-purified
fragments (Stratagene, La Jolla, CA). Generation of probe
fragments for Rho1 is described in [25], and for rp49 in [31].
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Protein isolation and western blot analysis
Non YFP-expressing embryos were isolated from 4 hour
collections of Rho1E(br)246/CyO, P{w+, Dfd-EYFP}, Rho1E(br)233/
CyO, P{w+, Dfd-EYFP}, or w1118 that were aged to be 12–16 hours
AEL, 16–20 AEL, or 20–24 hours AEL.,100 embryos from each
collection were dechorionated and lysed in 1X SDS sample buffer
[32]. The protein samples were boiled, separated on a 12% SDS-
PAGE, and transferred to PVDF membrane (Immun-Blot, Bio-
Rad, Hercules, CA) for 1 h at 100 V at 4uC. Blots were blocked in
5% nonfat milk in TBS plus 0.1% Tween-20 for 30 min. at room
temperature, and then incubated overnight at 4uC in primary
antibody. Anti-Rho1 (p1D9 from the Developmental Studies
Hybridoma Bank at the University of Iowa, Iowa City, IA) was
used at 1:500 and anti-b-tubulin (E7 from the DSHB) was used at
1:3,000. After incubation with horseradish peroxidase–coupled
secondary antibodies (Jackson ImmunoReseach Laboratories,
West Grove, PA), the immunoreactive proteins were visualized
using chemiluminescent detection (Pierce, Rockford, IL).
Deficiency screen
Second-site noncomplementation (SSNC) tests between autoso-
mal deficiencies (or specific mutations) and Rho1E(br)246 were
performed by mating eight to ten Rho1E(br)246/CyO, P{w+, ActGFP}
virgin females to eight to ten deficiency– or specific mutation–
bearing heterozygous males in vials. After 3 days the adults were
transferred to fresh vials, and then to a third vial after two
additional days. Newly eclosing F1 flies were separated by
genotype and examined for malformed legs each day for a total
of 10 days per vial. Subsequent secondary screening with
Rho1E(br)233 and Rho1E3.10 were performed in the same manner,
as were SSNC tests between Rho1-interacting deficiencies or
specific Rho1-interacting mutations and mutations in RhoGEF2 and
zip. SSNC tests involving X-linked deficiencies or mutations were
performed in a similar manner, but we reversed the sexes of the
crossed stocks (i.e. Rho1E(br)246/CyO, P{w+, ActGFP} males crossed
to deficiency-bearing hemizygous virgin females).
Prior to conducting the screen we considered five alleles of Rho1
(Rho1E(br)233, Rho1E(br)246, Rho1k02107b, Rho1J3.8 and Rho1E3.10) and
tested them with mutations in two known Rho1-interacting genes,
zip and RhoGEF2, at 21uC and 25uC. We considered an animal to
be malformed if it displayed even a single malformed leg, and
defined a leg as malformed if any femur, tibia or tarsal segment
was bent or twisted or was excessively short and fat (examples are
shown in Figure 1B–D). As shown in Table 1, only Rho1E(br)246/+
and Rho1E3.10/+ showed a background penetrance of malformed
legs less than 2% at either temperature (Rho1E(br)246/+ at 21uC and
Rho1E3.10/+ at both temperatures). Both of these Rho1 alleles are
also capable of being strongly enhanced by heterozygous
mutations in RhoGEF2 and zip, with Rho1E(br)246 showing a
modestly better interaction. Given the fact that Rho1E(br)246 is an
amorphic allele, whereas Rho1E3.10 is likely an antimorphic allele
[23], we decided to use Rho1E(br)246 for the screen. In addition,
although we observed stronger interactions at 25uC than 21uC for
all the Rho1 alleles, we decided to conduct the screen at 21uC since
the background level of malformations was lower at this
temperature, and thus would likely maximize our ability to
identify Rho1-interacting loci. Using these conditions, we estab-
lished our threshold for interaction at 10% malformed legs in
animals doubly heterozygous for Rho1E(br)246 and any deficiency or
specific mutation.
For the primary screen we used the Exelixis collection of
deficiencies maintained by the Bloomington Drosophila Stock
Center. It has been reported that these deficiencies collectively
uncover ,56% of the Drosophila genome (predicted genes; [27]),
although complementation tests conducted by the Drosophila stock
center have shown that at least 10% are not completely deficient
for the indicated intervals (http://flystocks.bio.indiana.edu/
Browse/df-dp/dfextract.php?num=all&symbol = exeldef), and
thus the collection provides closer to 50% coverage. It should be
noted that two of the stocks that passed our primary screen,
Df(1)Exel8196 and Df(1)Exel6253, were not tested by the stock
center, but all of the remaining deficiencies that we describe in the
text have been confirmed by the stock center.
Adult specimen preparations
Adult leg cuticles were prepared by dissecting legs from the third
thoracic segment of w1118, Rho1E(br)246/+, Rho1E(br)233/+, Rho1J3.8/
+, Rho1E(br)246/+;Df(3R)Exel6144, or Rho1E(br)246/Df(2R)Exel6065 in
PBS, clearing them overnight in 10% KOH, and mounting them
in Euporal (Bioquip, Gardena, CA) on microscope slides. Images
of adult leg cuticles were captured on a Photometrics CoolSNAP
ES high performance digital CCD camera mounted on a Nikon
Eclipse 80i microscope. Images of adult legs from live wild type
flies and flies overexpressing Tor signaling pathway genes were
captured on Photometrics CoolSNAP cf color digital CCD camera
mounted on a Leica MZFLIII stereomicroscope. All digital images
were cropped and adjusted for brightness and contrast in Adobe
Photoshop (version CS3, San Jose, CA).
Results
Characterization of newly isolated Rho1 alleles
Molecular characterizations of two new EMS-induced muta-
tions of Rho1 that we recovered from a modifier screen of br1 [25]
demonstrate that they are null alleles. Sequence analysis of
genomic DNA from Rho1E(br)246 embryos revealed a G/C to A/T
transition in the start codon (nucleotide 9130 from genomic clone
AF177871; Figure 2A). Consistent with this observation, we did
not detect any Rho1 protein by western blot or by indirect
immunofluorescence of fixed embryos in Rho1E(br)246 mutant
animals from 12 hr after egg laying (the earliest time point we
could unambiguously identify mutant embryos; Figure 2C and
data not shown). We also observed reduced Rho1 transcript levels
in mutant embryos (Figure 2B), raising the possibility that this
mutation engages a nonsense-mediated RNA decay pathway.
Similarly, genomic sequencing of Rho1E(br)233 revealed a G/C to
A/T transition at the invariant G in the splice donor site of the first
exon (nucleotide 9284 from AF177871; Figure 2A). Northern blot
analysis of total RNA isolated from 12–24 hour Rho1E(br)233
mutant embryos revealed nearly wild type levels of expression, but
altered Rho1 transcript sizes, consistent with a defect in splicing
(Figure 2B). We have not determined the nature of the altered
transcript since there are several potential splice donor sites in the
1.2 kb intron. The protein predicted from this allele would encode
the amino terminal 52 amino acids of Rho1 followed by 12 novel
(non-Rho1) amino acids before a premature stop codon.
Consistent with this result we do not detect any Rho1 protein
by western blot or by indirect immunofluorescence of fixed
embryos in Rho1E(br)233 mutant animals (Figure 2C and data not
shown), although the 1D4 anti-Rho1 monoclonal antibody
recognizes an epitope within the carboxyl-terminal 55 amino
acids [33], and therefore would not detect the mutant protein.
Together, these molecular characterizations suggest that
Rho1E(br)246 and Rho1E(br)233 are likely null alleles.
Genetic experiments on Rho1E(br)246 and Rho1E(br)233 support the
conclusions of the molecular data and demonstrate that they are
amorphic alleles. Rho1E(br)246 mutant embryos show complete
embryonic lethality with a nearly completely penetrant defect in
Rho1-Interaction Screen
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Figure 1. Representative malformed leg phenotypes in animals heterozygous for mutations in Rho1, or doubly heterozygous for
mutations in Rho1E(br)246 and specific Rho1-interacting deficiencies. Brightfield photomicrographs of representative adult legs from the third
thoracic segment ofw1118 (A), Rho1J3.8/Cyo (B), Rho1E(br)233/CyO (C), Rho1E(br)246/CyO (D), Rho1E(br)246/+;Df(3R)Exel6144/+ (E), and Rho1E(br)246/Df(2R)Exel6065 (F).
Femur (fe), tibia (ti), and the five tarsal segments (t1-t5) are labeled in (A). Some animals show short, fat femurs (arrows in B, C and E) or tibias (asterisk in B),
whereas others show tarsal segments that are short and fat, or are long and thin and occasionally show severe bends (arrowheads in C, D and F). Note that
malformations in all leg segments are seen with each Rho1 allele, and in the interaction between Rho1 alleles and specific Rho1-interacting deficiencies.
doi:10.1371/journal.pone.0007574.g001
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head involution (135/136 mutant embryos showed anterior open
defects). The phenotype is identical in penetrance and expressivity
to Rho1E(br)246/Df(2R)Jp8 (Figure 2D), and is consistent with the
zygotic loss of function phenotype reported for the strong loss of
function Rho1 allele reported by Magie et al. [12]. Similarly,
Rho1E(br)233 mutant embryos show complete embryonic lethality
with nearly completely penentrant head involution defects (data
not shown).
A second-site noncomplementation (SSNC) screen for
modifiers of Rho signaling during leg morphogenesis
In order to identify genes that function as part of a Rho
signaling pathway required for leg imaginal disc morphogenesis
during metamorphosis, we screened the Exelixis deficiency
collection [27] for deficiencies that increased the penetrance of
malformed legs in animals doubly heterozygous for the deficiency
and a loss of function allele of Rho1 (Examples of malformed legs in
animals doubly heterozygous for Rho1E(br)246 and specific deficien-
cies are shown in Figure 1E and F). The Exelixis collection consists
of ,500 molecularly-defined deficiencies generated by FLP-
mediated recombination of FRT-bearing P-element stocks. The
key advantages to this collection of deficiencies are that they were
generated in a near isogenic background, the deletions are small
(,140 kb on average), and the breakpoints are known. Prior to the
screen we conducted a series of control experiments to determine
which Rho allele and what conditions were best for conducting the
large-scale screen (details are presented in Materials and Methods).
It should be noted that all of the potential Rho1 alleles show a
dominant, partially penetrant malformed leg phentoype that varies
between 1 and 5 percent depending upon the allele and
temperature of development (Table 1; Figure 1B–D). From these
experiments we chose to use Rho1E(br)246 at 21uC for the screen,
and established a threshold for interaction at 10% malformed legs
in animals doubly heterozygous for Rho1E(br)246 and any deficiency
or specific mutation. Of the 461 deficiency stocks tested in the
primary screen, 18 reached this threshold (there were two
exceptions in which we observed an overall penetrance of 8%,
but at least one of the three vials tested showed greater than 10%
and we had additional evidence supporting the interval; see
below). The entire dataset is presented in Table S1.
Through extensive secondary screening we confirmed 12
regions as containing putative Rho1-interacting genes and refined
the intervals containing these genes (Table 2; the entire dataset
including all SSNC tests with deficiencies and specific mutations
for intervals that passed the primary screen is presented in Table
S2). To accomplish this we retested the 18 deficiencies that passed
the primary screen, along with additional overlapping deficiencies,
for SSNC with Rho1E(br)246, and then tested the primary deficiency
with two additional Rho1 alleles (Rho1E(br)233 and Rho1E3,10). After
these secondary tests, we considered that a region contains a Rho1-
interacting gene if the primary deficiency interacted with at least
two alleles of Rho1 and at least two overlapping deficiencies
interacted with an allele of Rho1 (one exception to this rule was
Df(1)Exel6253 in which overlapping deficiencies were not
available, see below). It should be noted that for the twelve
deficiencies that passed these secondary tests there was low
variability in the penetrance of malformed legs between the
primary screen and the subsequent retest. We first determined the
mean penetrance of malformed legs and the standard error of
measurement. We then calculated the standard error as a
percentage of the mean. Overall there was 18% variance around
the mean for all of these deficiencies, with a range from 0% of the
mean for Df(3R)Exel6144 to 34% of the mean for Df(3R)Exel7328.
Three of these interacting regions contain the previously
identified Rho1-interacting genes broad, RhoGEF2, and stubbloid,
and we have strong genetic evidence that another of the
interacting intervals is due to an interaction between Rho1 and
Cdc42. Further, our results indicate that Rheb and Sc2 interact
genetically with Rho1 during imaginal disc morphogenesis, and
that the Target of rapamycin (Tor) may also interact with Rho1 during
this process. The details of these interactions are presented below.
broad (br). Df(1)Exel8196 is predicted to uncover 18 genes
from cytological region 2B1 to 2B5, including br. Although the
deficiency stock was sick and we consistently obtained only small
numbers of Df/+;Rho1E(br)246/+ animals, we did observe
malformed legs at a frequency that placed this interval above
the threshold in the majority of the vials tested. Consistent with
this observation, Df(1)Exel8196 also showed SSNC with
Rho1E(br)233 and Rho1E3.10 (Table 2). Furthermore, a larger
Table 1. SSNC control data with select Rho1 alleles.
Genotypea
Temperature
(uC)
%Malformed
(n)b
Rho1E(br)246/+ 21 1.6 (689)
25 3.1 (878)
Rho1E(br)233/+ 21 3.1 (709)
25 4.9 (733)
Rho1E3.10/+ 21 1.0 (295)
25 0.7 (277)
Rho1k02107b/+ 21 4.7 (172)
25 4.1 (195)
Rho1J3.8/+ 21 2.0 (406)
25 3.1 (425)
Rho1E(br)246 +/+ RhoGEF211-3b 21 37 (252)
25 86 (43)
Rho1E(br)233 +/+ RhoGEF211-3b 21 31 (239)
25 75 (61)
Rho1E3.10 +/+ RhoGEF211-3b 21 20 (143)
25 20 (30)
Rho1k02107b +/+ RhoGEF211-3b 21 80 (5)
25 100 (9)
Rho1J3.8 +/+ RhoGEF211-3b 21 55 (62)
25 91 (22)
Rho1E(br)246 +/+ zipE(br) 21 50 (82)
25 66 (44)
Rho1E(br)233 +/+ zipE(br) 21 20 (102)
25 66 (29)
Rho1E3.10 +/+ zipE(br) 21 ND
25 33 (12)
Rho1k02107b +/+ zipE(br) 21 ND
25 ND
Rho1J3.8 +/+ zipE(br) 21 95 (20)
25 97 (30)
aBalanced, Rho heterozygous mutant virgin females were crossed to either
w1118 males, or males bearing RhoGEF2 or zip mutations over a second
chromosome balancer at 21uC and 25uC. b% malformed indicates the
percentage of animals of the indicated genotype showing a malformed leg
phenotype in at least one leg. n, total number of flies of the indicated
genotype that were scored. ND, not determined.
doi:10.1371/journal.pone.0007574.t001
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Figure 2. Molecular and genetic characterization of Rho1E(br)246 and Rho1E(br)233. (A) Schematic diagram of the Rho1 transcript. Exons are
indicated by boxes with coding regions filled in black. The locations of the Rho1E(br)246 and Rho1E(br)233 mutations are indicated above the diagram
and the molecular lesions are shown in the sequences below. 59 untranslated sequence and intronic sequences are written in lowercase letters while
coding sequence is written in capital letters. The ATG start codon is underlined. The number refers to the sequence from genomic clone AF177871.
(B) Northern blot analysis of total RNA isolated from w1118, Rho1E(br)246, and Rho1E(br)233 mutant embryos at 12–16 hrs, 16–20 hrs, and 20–24 hrs after
egg laying. Hybridization to rp49 was used as a control for loading and transfer, and indicates that the Rho1 samples are underloaded relative to
w1118. Hybridization of the blot with Rho1 indicates that Rho1E(br)246 produces substantially less Rho1 transcripts, whereas Rho1E(br)233 produces
transcripts at , wild type levels but with altered size. The two prominent bands in the w1118 samples are the 2.1 kb and 1.3 kb transcripts described
by [12]. (C) Western blot analysis of total protein lysate isolated from w1118, Rho1E(br)246, and Rho1E(br)233 mutant embryos at 12–16 hrs, 16–20 hrs, and
20–24 hrs after egg laying. No Rho protein is observed in Rho1E(br)246 or Rho1E(br)233 mutant embryos. b-Tubulin was used as a control for loading and
transfer. (D) Brightfield photomicrographs of cuticle preparations of w1118, Rho1E(br)246 and Rho1E(br)246/Df(2R)Jp8 mutant embryos. All animals are
shown with anterior to the left and the dorsal surface up. All Rho1E(br)246 and Rho1E(br)246/Df(2R)Jp8 mutant animals die as embryos, with nearly
completely penetrant defects in head involution (arrows point to dorsal anterior holes in the cuticle).
doi:10.1371/journal.pone.0007574.g002
Rho1-Interaction Screen
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Table 2. Summary of Rho1-interacting deficiencies and specific mutations.
% malformed (n)c
Primary screen Dfa
Secondary screen
Df or specific mutation Cytologyb Rho1E(br)246 Rho1E(br)233 Rho1E3.10
Df(1)Exel8196 2B1; 2B5 9 (78) 31 (42) 50 (28)
Df(1)A94 1E3; 2B12 48 (23)
br5 2B3-5 9 (33)d 8 (49)d
br1 2B3-5 18 (57)d 21 (38)d 62 (53)d
dor8 2B5 11 (61)
Df(1)Exel6245 11E11; 11F4 11 (46) 11 (47) 0 (84)
Df(1)N12 11D; 11F2 13 (82)
Df(1)C246 11D1; 12A1 13 (38)
Df(1)Exel6253 18D13; 18F2 11 (85) 25 (51) 18 (105)
Cdc421 18E1 52 (40) 47 (34) 47 (38)
Cdc423 18E1 9 (99) 13 (68) 27 (30)
Df(2L)Exel6017 27E4; 27F5 19 (54) 3 (124) 1 (107)
Df(2L)spdj2 27B2; 27F2 13 (122)
Df(2L)ED489 27E4; 28B1 12 (78)
Df(2L)Exel7055 34A2; 34A7 15 (65) 10 (52) 11 (105)
Df(2L)prd1.7 33B3; 34A2 0 (172)
Df(2L)ED776, 33E4; 34A3 1 (136)
Df(2L)ED777 33E7; 34A3 0 (72)
Df(2L)ED773 33E9; 34A3 0 (177)
Df(2L)ED778 33E9; 34A7 18 (89)
Df(2L)Exel8028 34A1; 34A2 0 (135)
Df(2L)ED774 34A3; 34A3 0 (121)
Df(2L)BSC30 34A3; 34B9 15 (89)
Df(2L)ED784 34A4; 34B6 32 (31)
Df(2L)Exel9023 34A6; 34A7 0 (211)
TorDeltaP 34A4 5 (354) 5 (195) 5 (129)
P{lacW}TorK17004 34A4 4 (161)
Df(2R)Exel7098 44D5; 44E3 10 (71) 14 (125) 9 (183)
Df(2R)ED1742 44B9; 44E3 11 (149)
Df(2R)H3D3 44D1; 44F5 8 (77)
Df(2R)ED1770 44D8; 45B4 55 (60) 60 (58) 23 (64)
Df(2R)Exel6065 53D14; 53F9 17 (163) 34 (127) 50 (70)
Df(2R)ED2751 53D14; 53F9 38 (128)
Df(2R)ED1 53E4; 53F9 31 (80)
PBac{RB}RhoGEF2e03784 53E4-F1 57 (28)
P{EPgy2}RhoGEF2EY08391 53E4-F1 17 (92)
RhoGEF211-3b 53E4-F1 37 (252)
Df(2R)Exel6098 63F2; 63F7 8 (120) 8 (76) 10 (72)
Df(3L)ED208 63C1; 63F5 23 (59) 35 (62) 56 (19)
Df(3L)ED4341 63F6; 64B9 10 (63)
Sc21 63F5 14 (133) 33 (131) 11 (80)
P{PZ}Sc205634 63F5 3 (139)
Sc2A4 63F5 4 (92)
Sc2F9 63F5 0 (95)
P{UASp-YFP.Rab8.Q67L}Sc210 63F5 0 (126)
Df(3R)Exel6144 83A6; 83B6 10 (249) 25 (87) 5 (111)
Df(3R)ED5177 83B4; 83B6 0 (61)
P{Mae-UAS.6.11}RhebAV4 83B2 8 (130) 14 (77) 4 (113)
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overlapping deficiency, Df(1)A94, also showed SSNC with
Rho1E(br)246. Since we previously identified Rho1E(br)246 and
Rho1E(br)233 as dominant modifiers of the malformed leg
phenotype associated with br1, and demonstrated that both Rho
alleles show SSNC with the amorphic allele br5 [25], we are
confident that the genetic interaction observed with this interval is
due to an interaction between Rho1 and br. It should be noted that
dor8 also showed SSNC with Rho1E(br)246 (Table 2), raising the
possibility that deep orange may also be a Rho1-interacting gene,
although thus far we have not followed up on this observation.
RhoGEF2. Df(2R)Exel6065 is a large molecularly defined
deficiency that uncovers 47 predicted genes in the cytological
interval 53D14 to 53F9. This deficiency displayed SSNC with all
three alleles of Rho1 tested (Table 2). In addition, Df(2R)ED2751, a
molecularly defined deficiency whose breakpoints are each within
200 bp of those for Df(2R)Exel6065, also shows SSNC with
Rho1E(br)246. In order to refine this interval we tested Df(2R)ED1
and observed a robust genetic interaction with Rho1E(br)246. This
molecularly defined deficiency has a left breakpoint within the first
intron of RhoGEF2 and a right breakpoint identical to
Df(2R)Exel6065. In total this deficiency is predicted to uncover
14 genes. There were loss of function alleles for four of these genes
and we tested all of them for interaction with Rho1E(br)246. We
observed SSNC with multiple RhoGEF2 alleles, but with none of
the other mutations (Table 2 and Table S2). The identification of
RhoGEF2 as a modifier for Rho1 during imaginal disc
morphogenesis supports earlier observations from Halsell and
Kiehart [23] and Bayer et al. [26].
Stubbloid (sbd). The final previously identified Rho1-
interacting gene we identified through the primary screen was
sbd. Df(3R)Exel7328 showed 8% malformed legs in the primary
screen, but several of the individual vials showed greater than 10%
malformations. We therefore tested this deficiency with
Rho1E(br)233 and Rho1E3.10 and observed much stronger
interactions (Table 2). This deficiency is predicted to uncover 29
genes between 89B1 and 89B9. From the primary screen, we
determined that an overlapping deficiency, Df(3R)Exel7327, does
not show SSNC with Rho1E(br)246. Df(3R)Exel7327 has a left
breakpoint in 89A8 and a right breakpoint in 89B3, thereby
limiting the interacting interval to 19 genes including sbd. An
overlapping deficiency, Df(3R)bxd100 (predicted interval: 89B6-
89E2), also shows SSNC with Rho1E(br)246, strongly supporting this
interval. Although we did not test any of the other genes in this
interval, we had previously shown a genetic interaction between
sbd and Rho1 [25], as had Bayer et al. [26].
Cdc42. We observed a SSNC between Df(1)Exel6253
(predicted interval: 18D13-18F2) and Rho1E(br)246, Rho1E(br)233
and Rho1E3.10. Although we were not able to confirm this finding
with an overlapping deficiency that also showed SSNC with
Rho1E(br)246, we were able to test loss of function alleles for 6 of the
32 genes predicted for this interval (all that had loss of function
alleles available from the Bloomington Drosophila stock center), and
found SSNC between two alleles of Cdc42 and all three tested
alleles of Rho1. The interaction was stronger with Cdc421 than with
Cdc423. In fact, Cdc421 showed a greater interaction with
Rho1E(br)246 than did Df(1)Exel6253, and produced very few
Cdc421/+; Rho1E(br)246/+ animals, although the other classes of
offspring were well represented. This observation is consistent with
a report that Cdc421 is an antimorphic allele [14].
Rheb. During the primary screen we observed SSNC between
Df(3R)Exel6144 (predicted interval 83A6-83B6) and both
Rho1E(br)246 and Rho1E(br)233. The Rho1-interacting region was
further refined by the lack of interaction between Rho1E(br)246 and
the molecularly defined deficiency Df(3R)ED5177 (predicted
% malformed (n)c
Primary screen Dfa
Secondary screen
Df or specific mutation Cytologyb Rho1E(br)246 Rho1E(br)233 Rho1E3.10
P{SUPor-P}RhebKG02006 83B2 3 (149)
P{EPgy2}RhebEY08085 83B2 2 (133)
P{Mae-UAS.6.11}RhebLA01053 83B2 4 (162)
Df(3R)Exel7328 89B1; 89B9 8 (227) 37 (84) 55 (116)
Df(3R)Exel7327 89A8; 89B3 3 (95)
Df(3R)bxd100 89B6; 89E2 18 (89)
SbdE(br)536 89B4-6 14 (72)d
Df(3R)Exel6178 90E7; 91A5 18 (212) 42 (85) 18 (152)
Df(3R)P14 90C2; 91B2 9 (68) 6 (82) 14 (59)
Df(3R)Cha7 90F1; 91F5 11 (76)
Df(3R)ED5815 90F4; 91B8 8 (75)
Df(3R)Exel6179 91A5; 91B5 12 (272) 21 (112) 11 (159)
Df(3R)Cha1a 91A2; 92A1 28 (46)
Df(3R)ED2 91A5; 91F1 15 (127) 28 (25)
Df(3R)BX5 91B1; 91D2 4 (134)
Df(3R)07280 91B2; 91C1 13 (125)
aExelixis deficiencies identified in the primary screen that interact with more than one Rho1 allele and have been confirmed by the identification of overlapping Rho1-
interacting deficiencies. bCytology is based upon flybase annotations as of January 2009 (reflects release 5 of the Drosophila genome). c% malformed indicates the
percentage of animals heterozygous for the indicated Rho1 allele and heterozygous for the indicated deficiency or specific mutation showing the malformed leg
phenotype in at least one leg. n, total number of flies of the indicated genotype that were scored. dData from [25].
doi:10.1371/journal.pone.0007574.t002
Table 2. Cont.
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interval 83B4-83B6), thereby limiting the region to 17 predicted
protein-coding genes and 16 small nucleolar RNA genes in 83A6-
83B4. We were able to test lethal alleles for eight of these genes,
seven of which showed no SSNC with Rho1E(br)246 (Table S2). The
final mutation, P{Mae-UAS.6.11}RhebAV4, showed SSNC with both
Rho1E(br)246 and Rho1E(br)233 (Table 2). This allele of Rheb is a P-
element insertion that has an UAS element to allow for
overexpression of Rheb, but the insertion also acts as a recessive
lethal allele of Rheb, resulting in slow growth and eventual death as
delayed first instar larvae [34]. Two additional P element alleles of
Rheb, P{Mae-UAS.6.11}RhebLA01053 and P{EPgy2}RhebEY08085,
failed to show SSNC with Rho1E(br)246 (Table 2).
Sc2. We observed a weak SSNC between Df(3L)Exel6098
(predicted interval 63F2-63F7) and Rho1E(br)246 during the primary
screen. We observed a similar interaction between this deficiency
and Rho1E(br)233 and Rho1E3.10. During the secondary screen we
observed a very strong SSNC between Rho1E(br)246 and
Df(3L)ED208, a molecularly defined deficiency with breakpoints
in 63C1 and 63F5. We also observed SSNC between Rho1E(br)246
and Df(3L)ED4341, another molecularly defined deficiency
(predicted interval: 63F6-64B9) that overlaps with
Df(3L)Exel6098, but not with Df(3L)ED208, suggesting that there
are likely two genes responsible for these interactions (Table 2).
One of these genes is predicted to map to interval 63F6-7 that
contains only four genes, Sc2, ida, mge, and Eip63F-1. We therefore
tested loss of function alleles for Sc2, ida and mge (all of the Eip63F-1
alleles are viable) and found SSNC between Sc21 and Rho1E(br)246,
Rho1E(br)233 and Rho1E3.10 (Table 2 and Table S2). Sc21 is an EMS
generated hypomorphic allele resulting in pupal lethality [35]. The
other three alleles of Sc2, however, showed 3-4% malformed legs
when heterozygous with Rho1E(br)246/+, and thus were deemed to
not interact. To identify the other potential Rho1-interacting gene
we tested mutations in 13 genes that mapped to the interval 63C1
to 63F5 for SSNC with Rho1E(br)246 (representing all of the genes
that had loss of function mutations available from the stock center).
None of these mutations, however, showed an interaction with
Rho1E(br)246 (Table S2).
Tor. We identified a SSNC between Rho1E(br)246 and
Df(2L)Exel7055 (predicted interval 34A2-34A7). Df(2L)Exel7055
also showed SSNC with Rho1E(br)233 and Rho1E3.10. To refine this
interval we tested ten additional deficiencies with three of them
interacting and seven failing to interact (Table 2). Using the
molecularly defined deficiencies, we were able to limit the Rho1-
interacting region to 13 potential genes between Target of rapamycin
(Tor) and Sir2 in 34A4-34A7. We tested loss of function alleles for
five of these genes (all that were available), but did not observe a
genetic interaction with any of them (Table S2). We did, however,
observe an interaction between TorDP and Rho1E(br)246 that,
although below our threshold, consistently gave 5% malformed
legs with all three tested Rho1 alleles. TorDP is a deletion resulting
from an imprecise excision of a P-element that removes the start
codon and the amino terminal 902 codons of Tor and thus is likely
an amorphic allele [36]. We tested a weaker loss of function allele
of Tor, P{lacW}Tork17004, but observed less than 5% malformed
legs with Rho1E(br)246 (Table 2).
Other Rho1-interacting loci. There are five additional
intervals that are predicted to contain Rho1-interacting genes
based upon the criteria outlined above: 11E11-11F2, 27E4-27F2,
44D8-44E3, 90F4-91A5, and 91A5-91B1. We have narrowed
these intervals as far as possible using all available molecularly
defined deficiencies, and in each case have tested putative loss of
function mutations for all the genes for which stocks are available,
but have not found any additional potential Rho1-interacting genes
(Table S2). Although we have carefully examined the lists of genes
for these remaining intervals, there are no obvious candidates for
Rho1-interacting genes, and thus the cloning and characterization
of these genes should provide novel insights into Rho1 signaling
during leg development.
Genetic interactions between Rho1-interacting
deficiencies and components of the Rho signaling
pathway
In order to further characterize the Rho1-interacting deficien-
cies, we crossed all of them (and several of the putative Rho1-
interacting specific mutations) to zipE(br) and RhoGEF211-3b, and
found that nine of the twelve deficiencies showed SSNC with at
least one of these mutations. This experiment was predicated on
previous studies reporting strong genetic interactions between
Rho1 and several components in the Rho signaling pathway,
including RhoGEF2 and zip, during leg imaginal disc development
[23–26]. We first determined the background level of malformed
legs in RhoGEF211-3b/+ and zipE(br)/+ adults. RhoGEF211-3b/+
adults showed malformed legs with a frequency of 1% (n=398)
regardless of the direction of the cross (for example, w1118 males
crossed to RhoGEF211-3b/CyO females), whereas the frequency of
malformations in zipE(br)/+ varied according to the sex of the
parents in the cross, with a higher frequency of malformed
progeny resulting from a cross in which the mother provided the
zipE(br) allele (2%, n=126 with zipE(br)/SM5 males and 6%, n=116
with zipE(br)/SM5 females). Since all of the autosomal deficiency
crosses were set up with zipE(br)/SM5 mothers, we considered an
interaction to be significant when the progeny showed 20% or
greater malformations, whereas we retained the 10% threshold for
all other crosses. As shown in Table 3, seven of the twelve Rho1-
interacting deficiencies showed SSNC with both zipE(br) and
RhoGEF211-3b (or failed to complement RhoGEF2 in the case of
Df(2R)Exel6065), strongly implicating genes uncovered by these
deficiencies in Rho signaling. It should be noted that
Df(2R)Exel7328, which removes sbd and showed the strongest
SSNC with RhoGEF211-3b, was not tested for interactions with
zipE(br), since genetic interactions between sbd and zip had been
well documented [25,26]. Two of the five remaining deficiencies
showed SSNC with zipE(br), but not with RhoGEF211-3b.
We next tested specific Rho1-interacting mutations and found
that Cdc421 strongly interacted with both zipE(br) and RhoGEF211-3b,
whereas Cdc423 did not interact with these mutations. We also
found some indication of an interaction between Sc21 and zipE(br),
although it was below the threshold we established. Similarly, we
observed a trend suggesting an interaction between RhebAV4 and
both zip and RhoGEF2 alleles, although in both cases the results
were just below the threshold. These results were encouraging,
however, and more strongly suggested an interaction between Rheb
and the Rho signaling pathway.
To further address the role of Rheb in leg morphogenesis, we
overexpressed Rheb in distal leg segments using a UAS-GAL4
approach [37] and observed severely malformed legs.
P{GawB}Dllmd23 flies express the yeast transcription factor GAL4
in the distal half of the tibia and in all the tarsal segments
throughout imaginal disc development, as well as in the wing
margin, the antennae, and mouth segments (see [38] for the
expression pattern of dll-GAL4 in prepupae and pupae). We
crossed two different UAS-Rheb transgenic lines to the
P{GawB}Dllmd23 stock, and in both cases observed offspring with
severely malformed legs and wings (100% malformed, n=45 with
P{UAS-Rheb.Pa}2 and 96% malformed, n=170 with P{UAS-
Rheb.Pa}3; Figure 3D, E). The malformations were characterized
by fat tarsal segments that were often nonuniform in diameter and
in many cases were kinked or curved. In addition, there was
Rho1-Interaction Screen
PLoS ONE | www.plosone.org 9 October 2009 | Volume 4 | Issue 10 | e7574
frequently a large kink in the femur, even though the transgene
was not expressed in this tissue. The wings tended to be smaller,
more delicate and slightly curved. Finally, we noticed a slight bend
in the middle tibia corresponding to the boundary of the Dll
expression domain with the segments distal to this point being
larger in general to those proximal to the boundary.
Rheb encodes a small GTPase known to activate Tor, which in
turn regulates cellular growth via increased protein synthesis and
inhibition of autophagy (reviewed in [39]). These proteins act in
the highly conserved PI3K/Tor signaling pathway (Figure 3A).
PI3 kinase (PI3K) is recruited to the plasma membrane in response
to activation of the insulin receptor. At the membrane PI3K
catalyzes the conversion of phophatidylinositol 4, 5-bisphosphate
into phosphatidylinositol 3, 4, 5-triphosphate (PIP3). Increased
levels of PIP3 at the membrane lead to the recruitment of the
serine/threonine kinase Akt to the membrane. Akt then negatively
regulates the GTPase activating proteins TSC1 and TSC2, which
negatively regulate Rheb. Thus recruiting PI3K to the membrane
ultimately results in the activation of Tor via Rheb. Since
overexpressing Rheb may be sufficient to activate Tor and thereby
increase growth, we wondered whether these phenotypes were
simply due to an increase in cell size for the cells in the Dll domain.
To address this we expressed P{UAS-PI3K92E.CAAX} with
P{GawB}Dllmd23. PI3K92E.CAAX encodes the PI3K92E coding
sequence with a farnesylation signal to target the recombinant
protein to the membrane and thereby produces a constitutively
active kinase. Flies expressing PI3K92E.CAAX in the Dll domain all
showed the enlarged distal tibia and tarsal segments (a phenotype
we referred to as ‘‘Popeye’’ legs), but very rarely showed any other
malformations. The most extreme malformations we typically
observed were the shorter fatter tarsal segments depicted in
Figure 3C. Thus the severe malformed leg phenotypes associated
with overexpression of Rheb are novel and independent of those
produced by activating the Tor signaling pathway.
Assessing potential RhoGEFs involved in leg
morphogenesis
RhoGEF2 is the only potential Rho-specific GEF that definitively
showed dose-sensitive interactions with Rho1 during leg morpho-
genesis, although two additional genomic intervals containing
potential RhoGEF genes also interacted with Rho1. Flybase [40]
lists 26 genes as having potential RhoGEF activity based upon
electronic annotation. Of these, 22 have Dbl homology (DH)
domains, and 15 have both DH and PH domains. Since most well-
described Rho-specific GEFs possess both a DH and a PH domain
[41], we focused our attention on these 15 genes. One of these
genes is identified only as a cDNA (GH16492), and thus is not
annotated to a particular chromosomal location. We also included
pebble (pbl), a known RhoGEF involved in cytokenesis that has a
DH domain and a BRCA1 carboxyl-terminal domain [42]. Of
these 15 genes, 7 of them are predicted to be deleted in at least one
of the Exelixis deficiencies used in the primary screen. Six of these
deficiencies showed no SSNC with Rho1E(br)246, whereas
Df(2R)Exel6065 showed strong SSNC with Rho1 and is deficient
for RhoGEF2 (Table 4). To test the remaining 8 potential RhoGEF
genes, we obtained deficiencies predicted to uncover these genes
from the Bloomington Drosophila stock center. Two of the
deficiencies were molecularly defined, whereas the remaining five
Table 3. SSNC tests between Rho1-interacting deficiencies and zip and RhoGEF2.
% malformed (n)b
Primary screen Df Specific mutation Cytologya zipE(br) RhoGEF211-3b
Df(1)Exel8196 2B1; 2B5 59 (39) 26 (14)
br1 2B5 24 (88) ND
Df(1)Exel6245 11E11; 11F4 13 (45) 3 (61)
Df(1)Exel6253 18D13; 18F2 13 (45) 24 (38)
Cdc421 18 E1 64 (36) 34 (47)
Cdc423 18 E1 8 (114) 4 (112)
Df(2L)Exel6017 27E4; 27F5 8 (107) 1 (150)
Df(2L)Exel7055 34A2; 34A7 33 (138) 10 (173)
TorDeltaP 34A4 9 (91) 3 (119)
Df(2R)Exel7098 44D5; 44E3 41 (86) 12 (135)
Df(2R)Exel6065 53D14; 53F9 77 (99) Failed to complement
Df(3L)Exel6098 63F2; 63F7 11 (88) 1 (127)
Sc21 63F5-6 17 (46) 1 (173)
Df(3R)Exel6144 83A6; 83B6 52 (61) 5 (148)
RhebAV4 83B2 19 (69) 9 (126)
Df(3R)Exel7328 89B1; 89B9 ND 38 (162)
sbdE(br)536 89B4-6 33 (73)c 2 (119)c
Df(3R)Exel6178 90E7; 91A5 51 (45) 14 (115)
Df(3R)Exel7179 91A5; 91B5 11 (111) 5 (174)
aCytology is based upon flybase annotations as of January 2009 (reflects release 5 of the Drosophila genome). b% malformed indicates the percentage of animals
heterozygous for the indicated Exelixis deficiency or specific mutation and heterozygous for zipE(br) or RhoGEF211-3b showing the malformed leg phenotype in at least
one leg. n, total number of flies of the indicated genotype that were scored. Background penetrance of malformed legs: RhoGEF211-3b/+ 1% (n= 398), zipE(br)/+ 2%
(n=126) with zipE(br)/SM5 fathers and 6% (n= 116) with zipE(br)/SM5 mothers. cData from [25].
doi:10.1371/journal.pone.0007574.t003
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were relatively large, randomly generated deficiencies (4 X-ray
induced and one generated by imprecise P element excision) with
the potential RhoGEF genes well within the predicted endpoints
of the deficiencies (Df(3L)pbl-X1 uncovers both pbl and CG33275).
Three of these seven deficiencies produced at least 10%
malformed legs when doubly heterozygous with Rho1E(br)246
(Table 4). Df(3R)ED5092 showed a SSNC of 12% with
Rho1E(br)246 and uncovered the potential RhoGEF Cdep. Cdep
encodes a protein with a FERM domain in addition to DH and
PH domains. We failed to detect an interaction with a piggybac
allele of Cdep (Table 4), although this allele is likely not
amorphic.We also observed a very strong SSNC between
Rho1E(br)246 and both Df(2R)nap11 and Df(2R)ED3636 (Table 4),
raising the possibility that CG30440 and/or CG30115 may act as
GEFs for Rho1 during leg morphogenesis. Unfortunately there
are no specific mutations for either gene, and we have therefore
not been able to test these genes directly. We have also thus far
not been able to refine these deficiency intervals, although we
have tested several specific mutations within the deficiencies and
have not identified candidate Rho1-interacting genes (data not
shown). Interestingly, Df(2R)nap11 is predicted to uncover genes
through 42F including the ecdysone receptor gene EcR. Since we
observed a strong genetic interaction between the ecdysone-
inducible transcription factor br and Rho1, we suspected that the
interaction between Df(2R)nap11 and Rho1E(br)246 might be due to
EcR. In contrast to this notion, however, we found no SSNC
between Rho1E(br)246 and the amorphic allele EcRm554fs (data not
shown). Finally, Df(2L)64j showed an overall interaction with
Rho1E(br)246 of 8% and uncovers Son of Sevenless (Sos), a Ras GEF
that also contains DH and PH domains. We therefore tested an
amorphic allele of Sos, Sos34Ea-6 and found no interaction with
Rho1E(br)246 (Table 4).
Figure 3. Overexpression of Rheb in distal leg segments results in a strongly penetrant malformed leg phenotype. (A) Model of the
PI3K/Tor signaling pathway. Details of the pathway are found in the text. (B) Control animals, in this case heterozygous for UAS-PI3K92E.CAAX, but
without a GAL4 driver, show normal leg morphology in live adults. Similarly, Dll-GAL4/+ and UAS-Rheb/+ adults have no leg malformations (not shown).
(C) UAS-PI3K92E.CAAX/+; Dll-GAL4/+ animals express activated PI3K in distal leg segments (distal to the arrow) that results in a growth advantage giving
the adults a ‘‘Popeye’’ leg phenotype. The most common morphogenesis defect is a slightly short, fat first tarsal segment (arrowhead). (D and E) Dll-
GAL4/+; UAS-Rheb/+ adults show a highly penetrant malformed leg phenotype independent of the ‘‘Popeye’’ growth phenotype. Mild phenotypes
include moderate to extreme short fat distal tibia and tarsal segments (arrowhead in E), whereas more extreme phenotypes include severely misshapen
and twisted segments (arrowhead in D). The edges of the wings are often curved while the overall size of the wing is reduced. These defects are often
accompanied by severe bends in the femur (white asterisk in E), even though the transgene is not expressed in this segment.
doi:10.1371/journal.pone.0007574.g003
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Discussion
A genetic screen for modifiers of Rho signaling during
leg morphogenesis
Using a deficiency-based genetic modifier screen that enabled us
to test ,50% of the genome, we identified 12 chromosomal
regions that contain Rho1-interacting genes necessary for leg
imaginal disc morphogenesis during metamorphosis in Drosophila.
Through extensive secondary screening we were able to identify
the likely Rho1-interacting gene for six of these intervals. Three of
these genes, RhoGEF2, broad and stubbloid, had previously been
shown to interact with Rho1 during leg development, validating the
screen. We additionally identified Cdc42, Rheb and Sc2 as new
Rho1-interacting genes necessary for leg imaginal disc morpho-
genesis, and observed a possible interaction between Rho1 and the
Target of rapamycin (Tor) in this process.
Two aspects of the screen greatly contributed to its success. First,
we identified an allele of Rho1, Rho1E(br)246, that has a very low
background of leg malformations when heterozygous and can be
strongly enhanced by second-site mutations in interacting genes. We
determined that this is an amorphic allele ofRho1, whichmakes this a
truly dose-sensitive interaction screen. The second key to the success
of this screen was the use of the Exelixis deficiency collection. The
near isogenic background of the stocks in this collection produced
essentially no leg malformations, which resulted in a relatively high
signal to noise ratio. When we remove the 18 intervals that were
deemed to have passed the primary screen, the average percentage
of malformed legs in the SSNC class for the remaining lines was
1.8% (as compared to the 1.7% malformations we observed in the
cross between Rho1E(br)246 and w1118; Table 1). Thus, in conjunction
with Rho1E(br)246, the identification of an interacting deficiency with
even a modest 6-8 fold increase over background was significant as
demonstrated by the fact that 67% of the intervals that were
identified in the primary screen were confirmed through the
secondary screen. We considered the screen to be successful based
upon recovering all possible previously identified Rho1-interacting
genes involved in leg morphogenesis (RhoGEF2; [23], br; [25], and
sbd; [26]). We would have also expected to identify deficiencies
uncovering zip (in 60E12 on 2R; [24]), and Rho kinase (in 14F2 on X;
[26]), but the Exelixis collection did not contain deficiencies for these
intervals. As a means to further characterize potential Rho1-
interacting genes we tested each interacting deficiency, as well as
specific mutations in candidate genes, for SSNC with alleles of zip
and RhoGEF2 (Table 3). Nine of the twelve Rho1-interacting
deficiencies showed SSNC with at least one of these mutations, as
did specific mutations in br, sbd, and Cdc42, with Rheb and Sc2
showing an interaction that was just below our stated threshold
(RhoGEF2 had already been shown to interact with zip and was not
tested). Taken together, these results indicate that the screen was very
successful in identifying genes that play important roles in Rho1
signaling during imaginal disc morphogenesis, and that the cloning
and characterization of the remaining Rho1-interacting genes will
likely provide important novel insights into this critical signaling
pathway. We will next describe the newly identified Rho1-interacting
genes and comment on their role in leg morphogenesis.
Cdc42. Cdc421 showed very strong interactions with all three
of the Rho1 alleles that we tested, as well as with RhoGEF211-3b and
zipE(br). Although Cdc421 is reported to be an antimorphic allele
[14], it does not have a dominant effect on leg morphogenesis
(data not shown). In addition, the weaker hypomorphic allele
Cdc423 also showed SSNC with all three alleles of Rho1. Together
these results support the identification of Cdc42 as the Rho1-
interacting gene responsible for the interacting interval identified
in 18D-F on the X chromosome.
Table 4. SSNC tests to assess potential RhoGEF genes.
Potential RhoGEF Cytologya Protein domainsb Df or mutation tested Cytologya % malf. (n)c
CG8557 16A5-B1 DH, PH Df(1)BK10 15F2; 16C10 0 (91)
vav 18B6-7 DH, PH, SH2, SH3, C1, CH Df(1)Exel9068 18B4; 18B6 0 (64)
Sos 34D1 DH, PH, RasGEF Df(2L)64j 34D1; 35C1 8 (255)
Sos34Ea-6 34D1 2 (133)
CG10188 37E4-5 DH, PH Df(2L)Exel8041 37D7; 37F2 0 (106)
rtGEF 38C5 DH, PH, SH3 Df(2L)Exel6046 38C2; 38C7 5 (21)
CG30440 41F2 DH, PH Df(2R)nap11 41E3; 42A10 54 (126)
RhoGEF2 53E4-F1 DH, PH, PDZ, C1 Df(2R)Exel6065 53D14; 53F9 17 (163)
CG30115 55D3-4 DH, PH Df(2R)ED3636 55B8; 55E3 67 (27)
RhoGEF3 61B3-C1 DH, PH, SH3 Df(3L)Exel6084 61B2; 61C1 6 (242)
trio 61E1-2 DH, PH, spectrin Df(3L)Exel6086 61C9; 61E1 0 (208)
sif 64E1-5 DH, PH, PDZ Df(3L)Exel6106 64D6; 64E2 4 (116)
RhoGEF4 65F4 DH, PH Df(3L)BSC33 65E10;65F6 4 (138)
pbl 66A18-19 DH, BRCT Df(3L)pbl-X1 65F3; 66B10 5 (147)
CG33275 66A6-8 DH, PH Df(3L)pbl-X1 65F3; 66B10 5 (147)
Cdep 82E2-3 DH, PH, FERM Df(3R)ED5092 82A3; 82E8 12 (104)
Pbac{5HPw+}CdepB122 82E2-3 4 (110)
aCytology is based upon flybase annotations as of January 2009 (reflects release 5 of the Drosophila genome). bDH, Dbl homology domain; PH, pleckstrin homology
domain; SH2, Src homology 2 domain; SH3, Src homology 3 domain; C1, Protein kinase C conserved region 1 domain; CH, Calponin homology domain; RasGEF, Ras
guanine nucleotide exchange factor domain; PDZ, domain found in PSD-95, Dlg and ZO 1/2; BRCT, BRCA1 C-terminal domain; FERM, Protein 4.1, Ezrin, Radixin, Moesin
homology domain. c% malformed indicates the percentage of animals heterozygous for the indicated Rho1 allele and heterozygous for the indicated deficiency or
specific mutation showing the malformed leg phenotype in at least one leg. n, total number of flies of the indicated genotype that were scored.
doi:10.1371/journal.pone.0007574.t004
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Cdc42 and Rho1 are closely related small GTPases that
likely regulate unique, but complementary processes required
for leg morphogenesis. In general, Cdc42 regulates the
cytoskeleton by controlling actin polymerization either
through the formin mDia2 or by regulating actin branching
through WASP and the ARP2/3 complex [43]. Rho can also
regulate actin polymerization directly through mDia, but is
also likely affecting leg morphogenesis through its regulation of
myosin activity, a pathway dependent on Rho kinase. It is
therefore possible that during leg morphogenesis Cdc42
regulates the actin cytoskeleton while Rho regulates myosin
to affect cell shape changes and cell rearrangements. Another
intriguing possibility is that Cdc42 and Rho1 are each
regulating distinct aspects of adherens junction plasticity
during the cell rearrangements that are occurring during the
early stages of leg morphogenesis. Cell rearrangements
necessitate the redistribution of junctional material as the
border between two adjacent cells either expands or shrinks. It
was recently shown that Cdc42 is required for the endocytosis
of DE-cadherin and other adherens junction proteins in the
early pupal notum, and that it carries out this function in
conjunction with Par6 and atypical Protein Kinase C, through
its downstream effectors WASP and ARP2/3 [44,45]. Al-
though the pupal notum is a fairly homeostatic tissue at this
time, this function of Cdc42 is likely also critical during the
more dynamic stages of tissue morphogenesis occurring
12 hours prior. Rho1 has also been shown to regulate the
adherens junction. Specifically, Rho1 localizes to the adherens
junction through its interaction with a-catenin and p120
catenin [33], and has been shown to regulate the distribution
of DE-cadherin at adherens junctions during embryonic
morphogenesis [46], likely through a mechanism dependent
upon its downstream effector diaphanous [47].
Rheb. During the primary screen we identified a potential
Rho1-interacting interval in 83A-B that we were not able to
verify with an overlapping deficiency, although we did limit the
potential interval to 17 protein-coding genes through non-
interacting deficiencies. In the course of testing 8 of these
potential Rho1-interacting genes, we identified a hypomorphic
allele of Rheb that showed SSNC with Rho1E(br)233 and was
close to reaching the threshold for SSNC with Rho1E(br)246
(Table 2). Although we failed to observe an interaction
between three additional P-element insertion alleles of Rheb
and Rho1E(br)246, we suggest that Rheb does interact with Rho1
during imaginal disc morphogenesis for the following reasons.
First, RhebAV4 behaved similarly in pattern and level of
interaction to Df(3R)Exel6144 with all three Rho1 alleles
tested (Table 2). Second, zipE(br)/+;RhebAV4/+ and RhoGE
F211-3b/+;RhebAV4/+ produced 19% and 9% malformed legs,
respectively, which although just below the threshold we
established for interaction, raises the possibility that Rheb
interacts with the Rho signaling pathway (Table 3). Finally,
overexpression of Rheb in distal leg segments resulted in a
nearly completely penetrant malformed leg phenotype
(Figure 3D, E).
An intriguing possibility is that there is an interaction between
the Rho1 and Target of rapamycin (Tor) signaling pathways
during imaginal disc morphogenesis. We observed an interaction
between Df(2L)Exel7055 and all three tested alleles of Rho1. We
subsequently limited the Rho1-interacting interval to 13 potential
genes including Tor (Table 2). Although we did not detect an
obvious interaction with Tor, we consistently observed a trend of
,5% SSNC between TorDP and all three Rho1 alleles (Table 2). In
addition, we observed nearly the same level of interaction between
another weak P element allele of Tor and Rho1E(br)246. Given the
low background in this study, these results stood out even if they
did not reach our threshold. In higher eukaryotes, a single TOR
protein participates in two functionally distinct protein complexes:
TOR complex 1 (TORC1) and TOR complex 2 (TORC2)
(reviewed in [48]). TORC1 is a central regulator of cellular growth
that integrates a number of growth promoting stimuli including
growth factors, low energy and nutrients to regulate ribosome
biogenesis and protein synthesis. TORC2 may also regulate cell
growth, but importantly also appears to regulate cell morphology
by mediating actin cytoskeletal modifications in response to
growth factors. Recent evidence indicates that it carries out this
function through the activation of Rac and Rho [49]. It is
conceivable that TORC2 acts upstream of the Rho1 signaling
pathway to regulate the actin cytoskeleton during the cell shape
changes and cell rearrangements that drive leg morphogenesis.
An alternative possibility is that Rheb interacts with Rho1
during leg morphogenesis in a pathway that is independent of its
role in regulating Tor. Our overexpression studies support this
notion. Overexpression of an activated PI3 kinase in distal leg
segments results in a highly penetrant growth advantage in those
tissues, producing larger distal tibias and tarsal segments with very
little overt malformations (Figure 3C). In contrast, overexpressing
a wild type Rheb transgene gave a consistently strong malformed
leg phenotype in addition to the growth advantage (Figure 3D, E).
We observed nearly identical results using two independent Rheb
transgenic lines. In addition, recent evidence suggests that
although Rheb has a well-described role as a key upstream
activator of TORC1, it may not activate TORC2, and in fact may
have an indirect inhibitory effect on TORC2 [50]. Furthermore,
clonal analysis of loss of function Rheb alleles in Drosophila imaginal
discs revealed unusual stretched and odd shaped clones that
caused the authors of the study to suggest that Rheb has other
functions in addition to growth control [51]. It will be interesting
to determine if the Rheb GTPase has effectors other than Tor and
how these potential effortors may intersect with the Rho1 signaling
pathway in imaginal disc morphogenesis.
Sc2. We identified a single hypomorphic allele of Sc2, Sc21,
which showed SSNC with all three Rho1 alleles, and also showed a
low level interaction with zipE(br). Four additional alleles of Sc2 did
not show an interaction with Rho1E(br)246, raising the possibility
that this potential interaction could be due to a second-site
mutation on the Sc21chromosome. The strongest evidence that this
is not the case is that Sc2 is one of only four genes deleted by two
overlapping Rho1-interacting deficiencies, and was the only one of
these genes to show an interaction with Rho1. Specifically, SSNC
tests indicated no interaction between Rho1E(br)246 and ida or mge
(Table S2). The final gene in this interval, Eip63F-1, is not essential
(Vaskova 2000), and is thus less likely to be the Rho1-interacting
gene. Sc2 encodes a 302 amino acid protein with two conserved
domains, an amino-terminal ubiquitin domain (IPR000626) and a
carboxyl-terminal 3-oxo-5-alpha-steroid 4-dehydrogenase domain
(IPR001104). This latter domain is highly conserved and catalyzes
the terminal step in the microsomal fatty acyl elongation cycle for
long chain and very long chain fatty acids (palmitic acid, C16, and
larger) [52]. How the synthesis of very long chain fatty acids
influences Rho1 signaling is unclear, especially since these
enzymes are not required for the synthesis of isoprenoids, and
thus not involved in the lipid modification of Rho proteins directly.
Rather, it might relate to the overall lipid composition of the
plasma membrane. Lipid rafts are specialized membrane
microdomains enriched in glycosphingolipids and cholesterol.
Numerous membrane proteins involved in signal transduction
events, including proteins that regulating Rho signaling, are
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enriched in these membrane domains [53]. Perhaps the regulated
expression of long chain fatty acids via Sc2 modulates lipid raft size
and composition, and thereby regulates signal transduction events
through Rho1. Additional work will be required to address this
hypothesis.
RhoGEF2 is a key regulator of Rho signaling during leg
morphogenesis
One question we were interested in addressing as part of this
study is which RhoGEF genes were likely functioning during
imaginal disc morphogenesis. Our results clearly demonstrate that
RhoGEF2 interacts genetically with Rho1 in this process (Table 2),
supporting previous work from Halsell et al. [23] and Bayer et al.
[26]. We found no evidence to definitively support any other
potential RhoGEF as interacting with Rho1 during leg develop-
ment, although we did identify two deficiencies that uncover
putative RhoGEF genes that strongly enhance the malformed leg
phenotype of Rho1E(br)246 (Table 4). Since there are no loss of
function alleles for these genes, we have not been able to address
them directly, and thus future studies are needed to test potential
roles for CG30440 and CG30115 in leg morphogenesis. It should
be noted that although we have no evidence to support a role for
other RhoGEF genes, it is not possible to exclude them as
functioning in leg morphogenesis if, for example, they are playing
a redundant role or are expressed at levels that render them less
dose sensitive.
Since it is clear that RhoGEF2 is functioning with Rho1 during
imaginal disc morphogenesis, an important next question is how is
RhoGEF2 activated in this process. Previous studies revealed that
the subcellular localization of RhoGEF2 shifts to the apical region
of cells destined to undergo apical constriction [54,55]. Since
RhoGEF2 has both PH and PDZ domains, its localization may be
mediated by the PIP3 level of the plasma membrane or by the
expression of a specific protein containing a PDZ binding site. Due
to the potential involvement of the Tor signaling pathway in leg
morphogenesis, we considered whether PI3 kinase was actively
altering the PIP3 content of the plasma membrane in these cells.
As an indirect means to assess the PIP3 content of the plasma
membrane, we examined prepupal leg imaginal discs from flies
expressing a fusion protein containing a PH domain linked to
green fluorescent protein (tGPH; [56]). We found no obvious
localization of the fusion protein to the plasma membrane in these
cells indicating low levels of PIP3 in leg disc cells at these times,
although as a control we could detect membrane localization of
tGPH in larval salivary glands and fat bodies as expected (data not
shown). Therefore these results suggest that RhoGEF2 is localized
(and likely activated) through the binding of a specific protein.
Perhaps the cloning of Rho1-interacting genes from the uniden-
tified intervals may shed light on this issue in the future.
Leg morphogenesis requires a complex interplay of individual
cell and collective tissue events, many of which are likely to be
regulated by Rho signaling. The identification of three novel Rho1-
interacting genes and six intervals containing novel Rho1-
interacting genes, many of which interact genetically with other
components of the Rho signaling pathway, provides a great
opportunity to define the role of Rho signaling in these distinct
morphogenetic events. Since this screen was predicated upon
observing defects in leg morphogenesis that persisted until the final
adult form of the appendage, it was not possible to determine
which of these processes was most affected by the interaction
between mutations in Rho1 and specific deficiencies or mutations.
Thus our future challenge is to more accurately define the cellular
events occurring during leg morphogenesis such that once we
clone the relevant Rho1-interacting genes, we can use loss of
function clonal analysis and induced RNA interference approach-
es to determine how these genes function during morphogenesis.
In addition, we anticipate that more genetic screens will be
performed to identify the Rho1-interacting genes playing critical
roles at other stages of development such as during gastrulation,
segment groove formation and head involution during embryo-
genesis. In this way we can define the myriad different Rho
signaling modules that function during distinct morphogenetic
processes during development, and may one day better understand
how Rho signaling can be subverted in pathological states
including tumor progression and metastasis.
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